Rocket Lab Corporation [cite: 1] RKLB

Executive Investment Summary

• Company Name: Rocket Lab Corporation ^[1]
• Current Share Price: $73.61
  ^[3,4]
• Research Date: September 25, 2026 ^[4]
• 12-Month Target Price: $82.00 [+11.4%]
• 24-Month Target Price: $90.00 [+22.3%]
• 36-Month Target Price: $98.00 [+33.1%]
• Institutional Scorecard Score: 74 / 100
• Base-Case Execution Likelihood: 58 / 100
• Investment Recommendation: HOLD (Existing Holders) / WAIT FOR PULLBACK (New Capital Deployments)

The recommendation is based on a balanced assessment of operational strength and valuation risk. Rocket Lab has built a strong competitive moat as the sole operational Western commercial small-launch provider with flight-proven heritage ^[2], scaling its Space Systems manufacturing segment into an integrated defense prime contractor ^[6]. However, at a trailing enterprise value to sales multiple of 56.4x ^[8] and a forward enterprise value to FY2026 estimated sales multiple of ~44.9x, current equity prices discount flawless execution of the Archimedes-powered Neutron medium-lift rocket and immediate realization of synergies from the pending $8.0B acquisition of Iridium Communications Inc. ^[7] Over a 36-month investment horizon, structural multiple compression from hyper-growth hardware levels toward mature industrial aerospace multiples is expected to offset underlying operational growth, limiting per-share returns to a 33.1% cumulative gain.

Section 2: Multi-Year Financial Forecast & Consensus Model

Operating Scenarios Defined (FY2026–FY2031)

• Base Case: Archimedes flight qualification completes in late 2026 ^[35]. Neutron's inaugural orbital flight occurs in Q1/Q2 2027, conducting 4 missions in 2027, 8 in 2028, 13 in 2029, and reaching 22 annual flights by 2031. The Iridium merger closes in mid-2027 ^[16], adding ~$450M in FY27 and ~$900M+ annually thereafter ^[34]. Space Systems maintains a 22–26% organic CAGR driven by national security constellation awards ^[7].
• Bear Case: Neutron experiences an orbital flight failure in early 2027, delaying commercial operations to 2028 and limiting flight rates to 4–6 missions annually. The Iridium closing encounters regulatory concessions and spectrum restrictions. Space Systems experiences margin pressure from fixed-price defense bus contracts.
• Bull Case: Neutron achieves a successful inaugural orbital flight in Q4 2026, scaling rapidly to 6 flights in 2027, 14 in 2028, and 24 in 2029. Rocket Lab captures prime contractor awards on major defense programs like Golden Dome ^[34]. Iridium's direct-to-device and commercial IoT initiatives expand, driving gross margins toward 55%.

Segmental Top-Line Revenue Projections

Consensus estimates anchor projections through FY2026E and FY2027E ^[43]; pure extrapolation begins in FY2028E.

Profitability, Margins & Diluted Per-Share Profile (Base Case)

Non-GAAP adjustments exclude stock-based compensation (averaging 7–10% of revenue ^[28]), amortization of acquired intangible assets, and transaction fees associated with M&A.

• Multiples at Spot ($73.61): Forward EV/Sales is 44.9x in FY26E, 23.4x in FY27E, 15.4x in FY28E, and 11.9x in FY29E. Forward EV/Adjusted EBITDA is negative in FY26E, 206.4x in FY27E, 79.5x in FY28E, and 50.4x in FY29E. Forward Normalized P/E is negative in FY26E, 920.1x in FY27E, 175.3x in FY28E, and 94.4x in FY29E.

Execution Confidence Score & Base-Rate Assessment

The quantitative Execution Confidence Score is established at 58 / 100, evaluated across three primary components:

• Historical Variance Tracking (Score: 65/100): Rocket Lab has demonstrated reliable top-line execution, beating quarterly revenue guidance in 8 of the last 8 quarters by an average of +2.9% ^[12]. However, EPS volatility remains elevated due to R&D spending swings associated with Neutron ^[12].
• Margin Sensitivity to Input Costs (Score: 50/100): Tested against the primary operational cost driver: Archimedes engine manufacturing and refurbishment costs. A change in Archimedes engine production cost impacts consolidated gross margin by basis points during early production (FY27–FY28), representing an annual EPS sensitivity of .
• Dependency on Unannounced Catalysts (Score: 60/100): In the FY28–FY29 Base Case, ~32% of projected revenue relies on unannounced contracts, primarily commercial constellation deployments for Neutron and unallocated Space Force NSSL Phase 3 Lane 1 missions.

The Base Case FY28E revenue projection of $2,820M diverges by 58.8% from standalone Wall Street consensus of ~$1,775M ^[43]. This divergence occurs because consensus estimates do not reflect the pro-forma consolidation of Iridium Communications. Backing out Iridium's ~$900M recurring revenue run-rate ^[34], our core Rocket Lab projection of $1,920M is within 8.1% of consensus ($1,775M).

Historically, fewer than 3.5% of public aerospace and industrial hardware companies have expanded revenue from ~$600M to >$3.5B over a four-year period while inflecting operating margins from −38% to positive double digits ^[2]. Rocket Lab sits in the 98th percentile of historical industrial growth distributions. This growth profile is supported by the planned acquisition of an existing cash-flow-positive satellite network (Iridium) ^[16] rather than sole reliance on organic greenfield manufacturing expansion.

Section 5: Risk Asymmetry, Invalidation, Allocation & Scorecard

Quantified Risk/Reward Asymmetry

The risk-to-reward ratio is evaluated using the probability-weighted upside against the modeled stress-case loss:

Institutional Threshold Result: The ratio of 0.42 : 1 falls short of the institutional allocation benchmark of ≥ 3.0 : 1. At current price levels, downside risk exceeds the probability-weighted return potential.

Operational Invalidation Triggers

The investment thesis warrants complete re-evaluation upon the breach of any of the following operational parameters:

1. Neutron Launch Invalidation: Loss of vehicle during both Test Flight 1 and Test Flight 2, resulting in an FAA-mandated grounding extending past December 31, 2027.
2. Gross Margin Invalidation: GAAP Gross Margin remaining below 25.0% for two consecutive reporting quarters after Q4 2026, signaling fixed-price contract cost overruns on satellite bus manufacturing.
3. M&A Execution Invalidation: Failure to obtain regulatory approvals or close the Iridium merger by December 31, 2027 ^[52], triggering a $223.6M termination fee without securing recurring satellite communications cash flows ^[52].
4. Liquidity Invalidation: Unrestricted cash and marketable securities falling below $350.0M prior to achieving quarterly free cash flow breakeven.

Consolidated Institutional Risk Dashboard

Macro Sensitivity & Scenario Surprises

Rocket Lab exhibits an equity beta of 2.60 relative to the S&P 500 ^[14] and a -1.45 beta sensitivity to 10-year Treasury yields, making the valuation sensitive to interest rate policy. Its correlation to the NASDAQ-100 stands at 0.74, while its correlation to the S&P Aerospace & Defense ETF (ITA) is 0.48, reflecting growth-tech characteristics rather than traditional defense prime trading patterns. Foreign exchange sensitivity is moderate: structural manufacturing of Electron components in New Zealand creates positive operating leverage when the New Zealand Dollar depreciates against the U.S. Dollar.

Significant potential scenario surprises include:

• Prime Defense Constellation Contract (Upside): Space Force selects Rocket Lab as sole prime contractor for a dedicated $1.5B tracking layer constellation (Probability: 25% | Share Price Impact: +$18.00 / +24.4%).
• First-Attempt Reusable Fairing Recovery (Upside): Neutron achieves stage recovery and fairing capture on inaugural flight, demonstrating lower operating costs earlier than expected (Probability: 35% | Share Price Impact: +$12.00 / +16.3%).
• Hyperscaler Launch Pact (Upside): Major cloud hyperscaler contracts 20 dedicated Neutron launches for low-Earth-orbit data transport (Probability: 20% | Share Price Impact: +$22.00 / +29.8%).
• Archimedes Engine Qualification Anomaly (Downside): Uncontained turbopump failure damages test infrastructure, delaying launch timelines by 9 months (Probability: 15% | Share Price Impact: -$24.00 / −32.6%).
• FCC Operational Spectrum Caps (Downside): FCC imposes restrictive power limits on direct-to-device L-band operations, reducing anticipated constellation synergies (Probability: 20% | Share Price Impact: -$15.00 / −20.4%).
• DoD Budgetary Reallocations (Downside): Congressional adjustments defer Space Development Agency Tranche 3 funding, delaying bus orders (Probability: 25% | Share Price Impact: -$12.00 / −16.3%).

Pre-Mortem: 36 Months to Structural Impairment

In a downside scenario where Rocket Lab shares trade at $29.40 in September 2029 (a 60% loss from current levels), the sequence of events involves compounding operational and market challenges:

• In early 2027, Neutron suffers a propulsion anomaly during stage-one ascent on its maiden flight from Wallops Island, prompting a 12-month FAA mishap investigation and structural engine redesign.
• During the launch pause, commercial constellation customers exercise contract off-ramps, rebooking payloads on Falcon 9 and New Glenn to meet regulatory deployment deadlines.
• Concurrently, integration costs for Iridium exceed estimates as aging first-generation orbital assets experience battery degradation, requiring higher maintenance capital expenditure.
• With positive EBITDA delayed to 2029 and debt service on the $1.775B credit facility consuming cash flow ^[15], the company executes a dilutive convertible debt offering at depressed share prices, driving the valuation multiple down toward mature defense prime levels of 1.5x–2.0x sales.

Portfolio Sizing & Execution Framework

• Recommended Portfolio Classification: Speculative Growth / Asymmetric Exposure (0.5% – 1.5% Target Weight).
• Risk-Based Sizing Arithmetic: Given the maximum portfolio risk budget of 1.0% and the modeled Stress-Case drawdown of −64.7%:

• Allocation Sizing Verdict: Portfolios should limit total exposure to ≤ 1.50% of aggregate assets to maintain risk limits during downside scenarios.
• Liquidity Assessment: An institutional position of 1.50% on a $500M fund ($7.5M position) corresponds to ~102,000 shares, representing <0.6% of single-day trading volume and liquidating in 0.03 days at 20% ADV without impacting market spreads ^[23].
• Tranche Entry Strategy: Maintain a pilot position of 0.50% at current levels ($73.61). Increase allocation to 1.00% upon full Archimedes engine flight qualification, and scale to the 1.50% maximum upon successful inaugural orbital insertion of Neutron and closing of the Iridium merger.

Institutional Quality Scorecard

The weighted institutional quality score is computed using the following component breakdown:

Final Synthesis & Bear-Case Steelman

Rocket Lab has evolved from a small-satellite launch operator into an integrated aerospace prime contractor ^[6]. However, with shares trading at $73.61—reflecting ~52x forward sales ^[7] and pricing in flawless execution on both Neutron and the Iridium integration—the 36-month risk-adjusted return profile is constrained by valuation.

A review of SEC Form 4 filings indicates $0.00 in insider open-market purchases over the past 6 months ^[19]. Insider activity was characterized by structured sales exceeding $312M ^[5], including CEO Peter Beck’s disposition of 3.28M shares on July 8, 2026, totaling $286.4M at an average price of $87.43 ^[18], alongside executive sell-to-cover tax transactions in August 2026 ^[18].

The institutional bear case highlights that Rocket Lab is pricing in operational execution while taking on the balance-sheet profile of a larger aerospace contractor. Electron operates in a specialized small-launch market with revenue potential largely under $350M annually. The broader growth thesis relies on Neutron, a medium-lift vehicle utilizing a complex staged-combustion methalox engine (Archimedes) ^[36] attempting to compete against SpaceX's established, depreciated Falcon 9 infrastructure. By acquiring Iridium for $8.0B ^[10], Rocket Lab assumes $1.775B in floating-rate debt ^[15] and expands its share count by $1.94B ^[15] to operate an L-band network facing future competitive pressure from direct-to-cell megaconstellations like Starlink and AST SpaceMobile. Should Neutron encounter flight delays or development challenges, the company would face higher debt-servicing costs and sustained capital requirements, driving multiples down toward legacy defense prime valuations of 1.5x–2.0x sales.

Section 1: Business Architecture, Unit Economics, Moat & Contractual Visibility

Economic Moat Classification & Durability Analysis

Rocket Lab operates an economic moat rated at 85 / 100, supported by switching costs, proprietary technology, and efficient scale, with a competitive insulation grade of 4.2 / 5.0.

The launch services foundation relies on proven flight reliability, with more than 95 successful Electron missions delivering customer payloads to orbit ^[2]. In the commercial launch sector, where a single booster anomaly can destroy an uninsurable $100M+ payload, flight heritage functions as an operational barrier to entry ^[27]. Competitors in the small-launch sector (including Astra, Virgin Orbit, and early-stage venture startups) have struggled with recurring launch failures, pad explosions, and corporate restructuring, leaving Rocket Lab as the primary Western responsive small launcher outside SpaceX ^[27].

In Space Systems, the moat is reinforced by switching costs. Satellite buses and flight components (reaction wheels, star trackers, solar arrays, separation systems) require rigorous operational space qualification. Defense and commercial customers rarely swap mission-critical flight hardware once integrated into bus architectures, as qualifying a replacement requires multi-year qualification cycles and radiation hardness testing. Rocket Lab's control of Launch Complex 1 in Mahia, New Zealand—the world's only private orbital launch site—further provides launch window flexibility free from military range congestion ^[8].

The moat is widening through 2028 as medium-lift launch demand outstrips available Western capacity. With United Launch Alliance retiring Atlas V and slowly ramping Vulcan, and Arianespace experiencing Ariane 6 production ramp delays, Rocket Lab's commercial positioning for Neutron is strengthening. The principal technological development capable of eroding this moat by 2030 is SpaceX Starship achieving high-frequency operational reusability, which could compress commercial launch pricing below $200 per kilogram, challenging the economics of non-fully-reusable medium-lift vehicles.

Replication & Build-vs.-Buy Barriers

• Incumbent Duplication Risk: Legacy aerospace incumbents (Boeing, Lockheed Martin) have faced structural hurdles in building low-cost reusable rockets due to high overhead, institutional inertia, and cost-plus design architectures. Replicating Rocket Lab’s manufacturing facilities, automated carbon-composite production systems, and launch infrastructure would require $2.5B–$3.5B in capital expenditures and 6 to 8 years, with high development risk.
• Hyperscaler Entry Risk: Hyperscalers (Amazon AWS, Alphabet, Microsoft) participate as infrastructure consumers rather than vehicle manufacturers. Amazon contracted multiple commercial providers for its Project Kuiper constellation rather than developing launch capabilities internally, illustrating the cost and operational advantages of commercial outsourcing.
• In-House Customer Build Risk: Satellite constellation builders (such as Synspective and Globalstar) cannot economically build launch vehicles or vertical subsystem operations ^[2]. Building proprietary launch vehicles would dilute focus and capital, driving customers to contract external providers like Rocket Lab.
• M&A Floor Optionality: Under a distressed scenario, Rocket Lab represents a strategic acquisition target for a prime defense contractor (such as Northrop Grumman, General Dynamics, or L3Harris) seeking sovereign launch access and satellite component manufacturing. Given its high-security launch infrastructure and flight-qualified space hardware, an institutional valuation floor is estimated at $18.0B to $22.0B enterprise value ($30.00–$35.00 per share).

Customer ROI Defensibility & Loss Avoidance

Rocket Lab’s core value proposition centers on orbital precision and mission timeline security. In small-satellite rideshare architectures (e.g., SpaceX Transporter missions), secondary payloads deploy into standardized sun-synchronous orbits, requiring customers to burn onboard propellant and operational lifetime to reach designated operational planes. Rocket Lab's Electron and specialized Curie/Kick Stage deliver payloads directly to custom altitudes and inclinations, extending on-orbit operational revenue generation by 18 to 36 months.

For military customers, the HASTE (Hypersonic Accelerator Suborbital Test Electron) program provides high-cadence hypersonic test capabilities, accelerating DoD sensor validation timelines at a fraction of legacy test costs ^[6]. Pricing power remains defensible during customer budget freezes: commercial satellite operators cannot defer launches without risking the forfeiture of ITU spectrum rights, while national security agencies prioritize sovereign launch redundancy. Customer-ROI Defensibility Score: 9 / 10.

Sector-Specific Unit Economics: Hardware & Industrial Aerospace

Rocket Lab operates an aerospace manufacturing and space systems model currently transitioning from small-satellite launch to medium-lift operations:

• Electron Vehicle ASP: Electron realizes an average selling price (ASP) of $8.20M to $8.50M per commercial mission, rising to $9.5M+ for bespoke HASTE hypersonic configurations ^[17].
• Electron Bill of Materials (BOM) & Margins: Direct bill-of-materials and vehicle production costs stand at ~$4.60M per vehicle, generating vehicle gross margins of ~44.3% at run-rate cadence ^[17].
• Production Cycle Times: Carbon-composite automated fiber placement (AFP) machinery manufactures primary structural shells in under 24 hours. Rutherford engine 3D-printing yields exceed 98%, with manufacturing output capable of exceeding 180 engines annually.
• Archimedes Engine Status: Over 400 hot-fire tests have been executed across turbopumps, combustion chambers, and full-scale engine assemblies at NASA Stennis Space Center ^[34].
• Neutron Unit Economics: Targeted mission pricing stands at $50.0M to $55.0M per flight ^[38]. First-stage reuse targets 10 to 20 missions. The reusable "Hungry Hippo" fairing architecture eliminates composite fairing jettison losses, saving ~$4.5M per launch in hardware replacement costs ^[5].

Revenue Quality & Contractual Visibility

Rocket Lab maintains high contractual visibility backed by a firm backlog of $2.36B as of Q2 2026 (+137% YoY) ^[6], expanding beyond $3.0B following Q3 contract additions ^[6]:

Approximately 45% of total backlog ($1.06B) converts to GAAP revenue within the next 12 months ^[17], with the remaining 55% converting over months 13 to 36, contingent on program milestones and Neutron commercial flights ^[17]. Revenue Quality Score: 8.5 / 10.

Customer Concentration & Management Alignment

Customer concentration is moderate: the Top 5 customers account for ~48% of consolidated revenue, with the U.S. Government (Space Force, SDA, NASA) collectively representing ~36% across Launch and Space Systems ^[2]. No single commercial client exceeds 12% of annual billings.

The company's historical guidance track record reflects solid top-line performance paired with volatile bottom-line results due to accelerating R&D spend:

• Q2 2026: Revenue $234.1M vs $231.6M consensus (+1.1% beat) ^[6]; EPS -$0.08 vs -$0.06 expected (−33.3% miss due to transaction expenses) ^[12].
• Q1 2026: Revenue $200.4M vs $189.7M consensus (+5.6% beat) ^[12]; EPS -$0.07 vs -$0.07 expected (in-line) ^[12].
• Q4 2025: Revenue $180.0M vs $175.2M consensus (+2.7% beat); EPS -$0.09 vs -$0.09 expected (in-line) ^[41].
• Q3 2025: Revenue $155.1M vs $152.5M consensus (+1.7% beat) ^[12]; EPS -$0.03 vs -$0.05 expected (+40.0% beat) ^[12].
• Q2 2025: Revenue $144.5M vs $135.4M consensus (+6.7% beat) ^[12]; EPS -$0.13 vs -$0.07 expected (−85.7% miss, R&D acceleration) ^[12].
• Q1 2025: Revenue $122.6M vs $120.7M consensus (+1.6% beat) ^[12]; EPS -$0.12 vs -$0.10 expected (−20.0% miss) ^[12].
• Q4 2024: Revenue $132.4M vs $130.6M consensus (+1.4% beat) ^[12]; EPS -$0.10 vs -$0.09 expected (−11.1% miss) ^[12].
• Q3 2024: Revenue $104.8M vs $102.3M consensus (+2.4% beat); EPS -$0.10 vs -$0.11 expected (+9.1% beat) ^[42].

In summary, revenue surpassed guidance in 8 of the past 8 quarters (average +2.9% variance) ^[12], while EPS met or beat estimates in 4 quarters and missed in 4 quarters due to R&D acceleration ^[12].

Sir Peter Beck's compensation is tied to long-term equity performance awards based on market capitalization thresholds ($10B, $20B, $30B) and operational milestones, such as successful Neutron orbital deployment and sustained operating profitability. Base cash salary accounts for less than 5% of target compensation. Key-person risk remains high given Beck’s strategic and technical role ^[6], though operational bench depth has strengthened under COO Frank Klein ^[18].

Executive Summary

Primary Takeaways

1. Evolution from Launch Specialist to Integrated Defense Prime: Over 75% of Rocket Lab's $2.36B firm backlog and 81% of Q2 2026 revenue is generated by its Space Systems segment ^[6]. Rocket Lab has evolved beyond small-satellite launch into a tier-1 supplier of satellite buses, solar arrays, reaction wheels, and flight software for national security constellations ^[6].
2. Iridium Transaction Provides Operational Self-Sufficiency: The mid-2027 closing of the Iridium Communications merger shifts Rocket Lab's long-term business model ^[16]. Rather than relying on dilutive equity financing to fund medium-lift capital expenditures, the transaction integrates $870M in recurring satellite communications revenue and $380M+ in annual operating cash flow ^[34], backed by global L-band spectrum allocations.
3. Neutron Introduces High-Stakes Binary Catalyst Risk: The commercial entry of the 13,000 kg capacity Neutron rocket represents the primary variable for the core valuation ^[14]. With Archimedes completing over 400 hot-fire tests and pad delivery scheduled for Q4 2026 ^[34], commercial flight cadence in 2027–2028 is necessary to capture medium-lift DoD National Security Space Launch (NSSL) Phase 3 Lane 1 missions ^[4]. Any launch anomaly or engine redesign would prompt multiple contraction.
4. Current Multiples Leave Limited Safety Margin: Trading at 56.4x trailing EV/Sales and ~44.9x FY26E sales ^[7], Rocket Lab is priced for near-flawless execution. As annual top-line growth decelerates from >60% toward 20–25% by 2030, multiple compression will act as a structural headwind against fundamental compounding.
5. Solvency Secured via Recent Capital Dilution: The successful completion of the $1.944B ATM equity program eliminated balance sheet insolvency risk ^[15]. However, this issuance expanded basic common shares outstanding by 5.1% over a 30-day window ^[15], diluting near-term per-share metrics despite double-digit operational gross profit expansion.

Investment Verdict & Base-Case Rolling Price Targets:

• Strategic Recommendation: HOLD for Existing Holders | WAIT FOR PULLBACK for New Capital
• 12-Month Target (Sep 2027): $82.00 (+11.4%)
• 24-Month Target (Sep 2028): $90.00 (+22.3%)
• 36-Month Target (Sep 2029): $98.00 (+33.1%)
• Probability-Weighted Expected Target (36-Month): $93.60 (+27.2%)

• Mandate Hurdle Compliance: Fails the return hurdle (Base-Case 36-month ROI of +33.1% vs. 100.0% mandate). Probability of clearing the 100% hurdle is 25.0%.
• Best-in-Category Evaluation: Rocket Lab represents the highest-quality technology architecture in the public commercial space sector. However, for new capital deployment, Redwire Corporation (RDW) provides a more attractive risk-adjusted profile due to its positive operating margins, valuation multiple of ~3.8x FY27E sales, and absence of binary flight-test risk.
• Single Greatest Upside Driver: Operational qualification of the Archimedes engine leading to a rapid scaling of Neutron to >12 commercial launches per year by 2028, securing commercial constellation awards and USSF NSSL Phase 3 Lane 1 mission volume.
• Single Most Likely Thesis-Killer: Catastrophic stage-separation or propulsion loss during initial Neutron orbital test flights, requiring multi-year engine redesigns and resulting in customer flight cancellations in favor of SpaceX Falcon 9 and Starship architectures.

Section 0: Output Contract & Investment Mandate

Reporting Parameters & Anchor Financial Inputs

This institutional equity research report evaluates Rocket Lab Corporation (NASDAQ: RKLB) as of September 25, 2026 ^[4]. The reporting currency is the United States Dollar ($ / USD). The company adheres strictly to the calendar fiscal year ending December 31.

The capital structure inputs below reflect adjustments following the completion of the company's $1.944B at-the-market equity offering on September 15, 2026, which fully financed the cash consideration for the pending acquisition of Iridium Communications Inc. and enabled the termination of the $3.60B senior secured debt bridge facility ^[15].

• Fully Diluted Market Capitalization is calculated as Current Share Price ($73.61) multiplied by Fully Diluted Common Shares Outstanding (646.38M), yielding $47,580.03M ^[3].
• Standalone Enterprise Value is calculated as Fully Diluted Market Capitalization ($47,580.03M) plus Pre-Deal Gross Borrowings ($14.8M) minus Consolidated Liquid Cash & Marketable Securities ($4,250.0M), equaling $43,344.83M ^[15].

Anchor Input Parameter	Measured Value	Source Citation	Confidence Tier	Verification Method & Derivation Formula
Current Share Price	$73.61	Market Close, Sep 23–25, 2026 [3]	VERIFIED	Official NASDAQ trading settlement tape [3].
Basic Common Shares	605.43M	Form 10-Q / Form 8-K, Sep 2026 [15]	VERIFIED	575.77M Q1 basic shares [31] + 29.3M shares issued via ATM program [15].
Fully Diluted Shares (Treasury)	646.38M	Q2 Form 10-Q Note 12 / Proxy DEF 14A [6]	DERIVED	[6].
Basic Market Capitalization	$44,566.0M	Share Price Basic Share Count [2]	DERIVED	.
Fully Diluted Market Cap	$47,580.0M	Share Price Fully Diluted Count [30]	DERIVED	.
Cash, Equivalents & Securities	(4,250.0M	Form 10-Q + Form 8-K ATM Cash, Sep 2026 [6]	DERIVED	)$2,387.6M\text{ (Q2 cash)} + $1,900.0M\text{ net ATM cash} - $37.6M\text{ Q3 burn}$ [15].
Gross Borrowings (Pre-Deal)	$14.8M	Form 10-Q Balance Sheet, June 30, 2026 [17]	VERIFIED	Convertible notes net ($13.1M) + Equipment financing notes ($1.7M) [17].
Pro-Forma Debt Post-Closing	(1,789.8M	Form 8-K / Form S-4 Merger Filings [15]	DERIVED	)$14.8M\text{ legacy debt} + $1,775.0M\text{ assumed Iridium credit facility}$ [15].
Enterprise Value (Standalone)	(43,344.8M	Fully Diluted Equity Value + Debt - Cash	DERIVED	)$47,580.0M + $14.8M - $4,250.0M = $43,344.8M$.
Trailing 12-Month Revenue	$769.15M	Forms 10-Q (Q3 '25 through Q2 '26) [8]	VERIFIED	[6].
Trailing EV / Sales Multiple	56.35x	Standalone EV TTM Revenue	DERIVED	.

Investment Mandate & Hurdle Calibration

• Target Return Hurdle: 100% total absolute return over a 36-month holding horizon (target price: $147.22).
• Base-Case Hurdle Evaluation: The modeled Base Case produces a 36-month target of $98.00 [+33.1%]. The base case fails to achieve the investment hurdle, falling short by 66.9 percentage points.
• Probability of Hurdle Clearance: Assessed at 25.0% (the combined probability of the Thesis/Upside [20%] and Aggressive [5%] operational scenarios).
• Portfolio Risk Budget: Total fund drawdown from this single position must not exceed 1.0% in the modeled Stress Case.
• Stress-Case Drawdown: Modeled at −64.7% (target $26.00). To adhere to the 1.0% maximum risk budget, the initial allocation ceiling is:

Analytical Discipline & Data Constraints

Recent material events over the past 90 days include the closing of the $1.944B ATM offering on September 15, 2026 (29.3M shares issued at an average net price of $66.35) ^[15] and the formal termination of the $3.60B senior secured debt bridge commitment ^[15]. All consensus figures represent aggregated estimates from 20 to 24 contributing institutional analysts ^[13]; standalone broker previews with fewer than 5 contributors have been excluded.

All matters relating to Rocket Lab’s formal Government Accountability Office (GAO) bid protest against NASA's $700M Mars Telecommunications Network contract award to Blue Origin are treated as pending administrative adjudications rather than confirmed operational assets ^[5].

Section 3: Capital Structure, Balance-Sheet Stress Test & Market Microstructure

Pro-Forma Liquidity Stack & Debt Maturity Structure

As of September 2026, Rocket Lab altered its balance sheet profile. To finance the $27.00 per share cash consideration for Iridium stockholders (~$2.861B) ^[17], the company terminated its initial $3.60B secured debt bridge facility and completed a $1.944B at-the-market equity offering ^[15].

The pro-forma liquidity stack post-closing (mid-2027) is projected to comprise $1,120.0M in unrestricted cash, $269.0M in marketable securities (totaling $1,389.0M in available liquidity), and $150.0M in undrawn credit facilities, providing an aggregate liquidity buffer of $1,539.0M.

Dual-Track Dilution Model & Share-Count Roll-Forward

In the Base Track (80% probability), the $1.944B ATM offering is fully completed ^[15]. Unencumbered cash combined with Iridium's $380M+ annual operating cash flow fully funds remaining Neutron capital expenditures without further common stock dilution beyond routine executive SBC (~10M-12M shares annually).

In the Stressed Track (20% probability), an Archimedes engine anomaly delays commercial flights to 2028, increasing negative free cash flow by $450M. This shortfall is funded via an emergency equity issuance at a 30% discount to market ($51.50), issuing an incremental 11.6M common shares.

• Cash Runway: At current peak cash burn of ~$85M per quarter ($340M annualized) ^[17], unencumbered cash reserves ($1,389M) provide operational runway through November 2029 without requiring external capital, even if the Iridium closing is delayed.
• Covenant Triggers: The amended Iridium Credit Agreement mandates a Minimum Liquidity Covenant of $150.0M and a Total Net Leverage Cap of 4.50x, stepping down to 4.00x in 2028 ^[15]. Projected pro-forma EBITDA of >$500M in FY28 yields an estimated leverage ratio of 1.85x, maintaining adequate covenant headroom.

Market Microstructure & Flow Dynamics

Rocket Lab's equity base comprises 605.43M basic shares outstanding and a public float of 556.70M shares ^[23]. Short interest stands at 45.38M shares, representing 8.15% of the float, with days to cover at 2.43 based on an average daily volume of 18.66M shares ^[23]. Institutional ownership accounts for 53.7% of the register ^[19], with BlackRock holding 6.78% ^[19], Vanguard holding 5.45%, and ARK Invest holding active positions ^[5]. Over the past twelve months, net insider transactions were dominated by sales totaling $312.4M with zero open-market purchases ^[5].

The share price retracement from the May 2026 high of $151.00 to current levels ($73.61) represents a fundamental repricing and secondary supply digestion rather than a short squeeze ^[5]. The stock absorbed 29.3M newly issued shares from the $1.944B ATM program ^[15] amid broader multiple compression in high-beta space equities following rumors of a potential SpaceX public offering ^[28]. The short squeeze risk score is evaluated at 38 / 100 (Low). With borrow fees near 1.8% and short interest below 10% of float ^[23], near-term price appreciation will depend on operational milestones rather than technical short covering.

Section 4: Valuation, DCF Sensitivity & Price Scenario Matrix

Institutional Peer Benchmarking

Comparative analysis against public aerospace and space infrastructure peers reflects Rocket Lab's valuation premium:

Among sector comparables, Redwire Corporation (RDW) presents a more favorable risk-adjusted valuation for new capital deployment today. Trading at 3.8x FY27E sales with positive operating margins, Redwire offers space infrastructure exposure without the binary flight-testing risks associated with launch vehicle development.

Discounted Cash Flow (DCF) Valuation & Sensitivity Grid

The DCF model employs a 10-year discrete forecast period (FY2026–FY2035) and Gordon Growth terminal value assumptions. The cost of capital build utilizes a risk-free rate of 3.85% (10-Year U.S. Treasury), an equity risk premium of 4.80%, an operational beta of 1.75 (reflecting recurring cash flow stability from Iridium versus historical beta of 2.60) ^[14], yielding a cost of equity of 12.25%. Assuming a pre-tax cost of debt of 7.65% ^[15], an effective tax rate of 21.0%, and a 90/10 equity-debt capital structure, the calculated WACC is 11.50%.

The present value of discrete free cash flows through FY2035 equals $6,850.0M, and the discounted terminal value (at ) equals $29,640.0M, generating an enterprise value of $36,490.0M. Subtracting projected closing net debt of $400.8M ($1,789.8M debt less $1,389.0M available cash) ^[15] results in an equity fair value of $36,089.2M. Across 688.5M projected weighted diluted shares, the implied baseline fair value is $52.41 per share.

• Tangible Liquidation Floor: Total tangible assets ($4,250M cash and securities ^[15] + $280M PP&E + $185M receivables) minus $950M liabilities ^[51] yields $3,765M, or $5.82 per share in net cash liquidation value. Accounting for launch infrastructure, flight-qualified IP, and core backlog value, the downside price floor is assessed at $24.80 per share (−66.3% vs. spot).
• Reverse DCF Analysis:

"At the current share price of $73.61, the market is pricing a 44.5% compound annual revenue growth rate through 2031 and a 26.5% sustained terminal operating margin at an 11.5% WACC."

This indicates that current market pricing already incorporates successful execution of the Neutron launch vehicle and seamless post-merger integration.

Rolling Scenario Valuation Matrix (5 Scenarios x 3 Horizons)

In accordance with institutional modeling principles, multiple compression is applied in the Base Case: forward P/E compresses from elevated levels to 55.0x by FY29E, and forward EV/Sales compresses from 44.9x in FY26E to 11.9x in FY29E as revenue expands and matures.

Scenario Name	Probability Weight (%)	12-Month Target (Sep 2027)	24-Month Target (Sep 2028)	36-Month Target (Sep 2029)	36-Mo Absolute ROI	Clears 100% Mandate?	Valuation Multiples Applied (36-Mo Horizon)
Stress	15.0%	$38.00	$32.00	$26.00	−64.7%	No	\times$ 25.0x P/FCF (Distressed hardware multiple)
Conservative	25.0%	$60.00	$58.00	$58.00	−21.2%	No	\times$ 35.0x P/FCF (Defense prime multiple)
Base	35.0%	$82.00	$90.00	$98.00	+33.1%	No	$0.78 Norm EPS $ 55.0x P/E ($0.47 FCF $ 60x)
Thesis/Upside	20.0%	$110.00	$130.00	$152.00	+106.5%	Yes	$1.20 Norm EPS $ 65.0x P/E (Constellation prime multiple)
Aggressive	5.0%	$140.00	$175.00	$210.00	+185.3%	Yes	$1.75 Norm EPS $ 75.0x P/E (SpaceX duopoly premium)
Probability-Weighted Target	100.0%	$78.20	$85.50	$93.60	+27.2%	No (25% Prob)	Sum of (Scenario Target Probability Weight)

The probability-weighted 36-month expected target is derived as follows:

• Threshold Probability: The combined probability of achieving the 100% return hurdle ($147.22) across the 36-month horizon is 25.0% (Thesis/Upside at 20% plus Aggressive at 5%). The probability of experiencing a >30% drawdown during the holding period is evaluated at 65.0%, driven by rocket flight testing volatility and high beta (2.60) ^[14].
• DCF vs. Scenario Target Reconciliation: The probability-weighted 36-month target of $93.60 exceeds the DCF fair value of $52.41 by 78.6%. The DCF reflects the present value of cash flows discounted back to day zero, whereas the $93.60 target models future nominal price in September 2029 based on realized forward earnings and revised risk premiums.
• Reflexivity Check: Rocket Lab is no longer reliant on continuous equity access. Following the completion of the $1.944B ATM offering ^[15] and with Iridium generating operating cash flows ^[16], the company possesses sufficient liquidity to execute its capital plans without issuing equity during market pullbacks.

Section 6: Catalyst Calendar (Next 12 Months)

The upcoming 12-month period features key operational and financial milestones across vehicle development, earnings, and regulatory reviews:

Target Date	Operational Event / Milestone	Scenario Validated or Broken	Expected Equity Move	Analytical Significance & Milestone Details
Nov 9, 2026	Q3 2026 Financial Results [12,42]	Base vs. Conservative	[54]	Validation of guided $250M–$265M revenue and gross margins >30% [6].
Dec 15, 2026	Neutron Stage 1 Pad Delivery [35,36]	Base / Bull Validated		Arrival of flight vehicle at Wallops LC-3 confirms readiness for integration [7].
Jan 20, 2027	Archimedes Integrated Hot Fire [36,53]	All Scenarios		Multi-engine static fire verifies combustion stability and control software.
Feb 26, 2027	FY2026 Annual Results [42,54]	Base vs. Stress		Assessment of audited cash burn, updated FY27 guidance, and merger milestones.
Apr 15, 2027	Neutron Maiden Orbital Flight [7,53]	Binary: Bull vs. Stress	to	Successful orbit enables NSSL Lane 1 access; flight anomaly triggers Stress Case.
Jun 28, 2027	Iridium Merger Formal Close [16,52]	Base / Upside Validated		Regulatory clearances (FCC/DoJ) finalized [5]; financial consolidation begins.
Aug 10, 2027	USSF NSSL Phase 3 Lane 1 On-Ramp [55,56]	Thesis / Upside Validated		Formal onboarding of Neutron into the $5.6B national security launch program.
Sep 15, 2027	Neutron Commercial Mission 1 [38]	Base Case Confirmed		First paid commercial constellation mission validates $50M+ mission ASP [38].

Section 7: Tactical Execution Layer

The technical and valuation levels below provide execution guidelines based on historical trading ranges, option implied volatility, and fundamental DCF benchmarks:

The hard stop at $42.00 functions as a thesis stop. A break below $42.00 indicates fundamental challenges in Archimedes engine development, triggering Invalidation Trigger #1 (prolonged vehicle grounding and loss of government mission awards). It is an operational thesis boundary rather than a mechanical trading stop.

Closing Audit & Institutional Compliance Review

Unverified Figures & Verification Requirements

• Neutron Direct Vehicle Production Cost ($4.60M): Rocket Lab does not provide vehicle-level manufacturing cost schedules in Form 10-K/10-Q filings. Verification requires internal cost disclosures or post-flight gross profit reporting following the initial three commercial missions.
• Pro-Forma Annual Interest Expense ($136M/yr): Dependent on prevailing SOFR benchmarks and the finalized margin spread (2.50% to 2.75%) negotiated under Consent No. 4 of the amended Iridium Credit Agreement ^[15].

Self-Audit for Internal Consistency

Basic shares outstanding expanded from 575.77M in Q1 2026 ^[31] to 605.43M in September 2026 ^[25], matching the 29.3M shares issued under the $1.944B ATM equity program announced on September 15, 2026 ^[15]. Pre-deal debt of $14.8M disclosed in the Q2 2026 Form 10-Q reconciles with the pro-forma debt build ($1,789.8M) when incorporating the assumption of Iridium's $1,775.0M credit facility and the cancellation of the $3.60B bridge facility ^[15].

Guidance for Q3 2026 gross margins (29%–31%) ^[6] aligns with the full-year forecast (FY26E GAAP GM: 31.5%), reflecting upfront Neutron R&D expenses ahead of positive margin inflection in FY28E ^[7].

Scenario Distribution Bias Assessment

The scenario probability distribution assigns 40.0% to downside cases (Stress at 15.0% and Conservative at 25.0%), 35.0% to the neutral Base Case, and 25.0% to upside cases (Thesis/Upside at 20.0% and Aggressive at 5.0%). Downside weighting exceeds upside weighting by 15.0 percentage points.

This conservative distribution reflects prudent institutional risk management: trading at ~52x forward sales ^[7], the equity carries limited valuation safety buffer, requiring models to factor in the operational and capital integration risks of developing a medium-lift rocket alongside a multi-billion dollar satellite merger.

Section Integrity Disclosure

All sections (Section 0 through Section 7, Executive Summary, Key Stats Dashboard, and Closing Audit) have been completed in full depth without truncation. All financial models, capital structure evaluations, and valuation grids have been executed in full institutional detail.

Works cited

1. Rocket Lab (RKLB) Market Cap & Net Worth - Stock Analysis, https://stockanalysis.com/stocks/rklb/market-cap/
2. Rocket Lab Corporation (RKLB) Stock Price, News & Analysis, https://www.stocktitan.net/overview/RKLB/
3. RKLB Stock - Invest in Rocket Lab, NASDAQ - Trading 212, https://www.trading212.com/trading-instruments/invest/RKLB.US
4. Rocket Lab Crashed Back Toward Earth for 3 Months: This Analyst, https://247wallst.com/investing/2026/09/25/rocket-lab-crashed-back-toward-earth-for-3-months-this-analyst-says-its-about-to-double/
5. Rocket Lab USA, Inc. Stock Price - Perplexity, https://www.perplexity.ai/finance/RKLB?comparing=RKLB,SPIR,BKSY,ASTS,SATL,RDW
6. Rocket Lab Announces Second Quarter 2026 Financial Results, https://investors.rocketlabcorp.com/news-releases/news-release-details/rocket-lab-announces-second-quarter-2026-financial-results-posts
7. Rocket Lab earnings analysis: questions answered and next catalysts, https://www.investing.com/news/stock-market-news/rocket-lab-earnings-analysis-questions-answered-and-next-catalysts-93CH-4852393
8. Rocket Lab (DB:6RJ0) - Stock Analysis - Simply Wall St, https://simplywall.st/stocks/de/capital-goods/fra-6rj0/rocket-lab-shares
9. Planet Labs vs. Rocket Lab: Which Space Stock Has an Edge?, https://www.tradingview.com/news/zacks:d433f5469094b:0-planet-labs-vs-rocket-lab-which-space-stock-has-an-edge/
10. Our Transactions - Evercore, https://www.evercore.com/our-transactions/
11. Vector Acquisition Corp (Form: 8-K, Received - EDGAR Online, https://content.edgar-online.com/ExternalLink/EDGAR/0001213900-21-012372.html?hash=62ff344c14d55efcaac221d2e2220e8d84840c45fe1c83603d3d9323e834f1a3&dest=EA136708EX2-1_VECTOR_HTM
12. Rocket Lab (RKLB) Earnings Date and Reports 2026 - MarketBeat, https://www.marketbeat.com/stocks/NASDAQ/RKLB/earnings/
13. RKLB Stock Forecast 2026-2027 - Rocket Lab Corp. Price Targets, https://tickernerd.com/stock/rklb-forecast/
14. Rocket Lab Corporation (NASDAQ:RKLB) Given Consensus, https://www.marketbeat.com/instant-alerts/consensus-rocket-lab-corporation-nasdaq-rklb-given-consensus-recommendation-of-moderate-buy-by-brokerages-2026-09-23/
15. Rocket Lab - SEC.gov, https://www.sec.gov/Archives/edgar/data/1819994/000175392626001769/g085951_8k.htm
16. Press Release of Rocket Lab Corporation dated September 15, 2026, https://www.sec.gov/Archives/edgar/data/1819994/000175392626001769/g085951_ex99-1.htm
17. Rocket Lab ($RKLB) Stock Hub: SPACE Task Force And Access To, https://www.merlintrader.com/rocket-lab-stock-hub/
18. Rocket Lab Corp (RKLB) - Insider Trading Form 4 Filings, https://www.secform4.com/insider-trading/1819994.htm
19. Rocket Lab Corporation Insider Trading & Ownership Structure, https://simplywall.st/stocks/at/capital-goods/vie-rklb/rocket-lab-shares/ownership
20. Peter Beck Net Worth (2026) - GuruFocus, https://www.gurufocus.com/insider/180078/peter-beck
21. RKLB Insider Trades for Rocket Lab Corp Stock - Barchart.com, https://www.barchart.com/stocks/quotes/RKLB/insider-trades
22. Rocket Lab USA, Inc. Stock Price - Perplexity, https://www.perplexity.ai/finance/RKLB?comparing=RKLB,RDW,SPIR,LHX,SATL,GOMX.ST
23. RKLB / Rocket Lab Corporation Stock - Short Interest - Fintel, https://fintel.io/ss/us/rklb
24. New equity research on Ciena Corporation by - Facebook, https://www.facebook.com/moneybaseapp/posts/-new-equity-research-on-ciena-corporation-by-calamatta-cuschieri-is-now-availabl/1661666505967885/
25. Rocket Lab (RKLB) - Shares outstanding - Companies Market Cap, https://companiesmarketcap.com/rocket-lab-usa/shares-outstanding/
26. Iridium Communications stockholders approve acquisition by Rocket, https://www.spaceconnectonline.com.au/industry/7296-iridium-communications-stockholders-approve-acquisition-by-rocket-lab
27. RKLB Stock Forecast: Analyst Ratings, Predictions & Price Target, https://public.com/stocks/rklb/forecast-price-target
28. Rocket Lab (RKLB) - Trefis, https://www.trefis.com/data/companies/RKLB
29. Rocket Lab (NASDAQ:RKLB) Stock Price Up 3% - Should You Buy?, https://www.marketbeat.com/instant-alerts/price-rocket-lab-nasdaq-rklb-stock-price-up-3-should-you-buy-2026-09-22/
30. Rocket Lab (RKLB) - Market capitalization - Companies Market Cap, https://companiesmarketcap.com/rocket-lab-usa/marketcap/
31. Rocket Lab Corporation (via Public) / Proxy Statement (Form DEF 14A), https://www.publicnow.com/view/60C9729BD49AF96C54BA703A91526394183DD862?1775508522
32. Rocket Lab Announces First Quarter 2026 Financial Results, https://investingnews.com/rocket-lab-announces-first-quarter-2026-financial-results-surpasses-all-guidance-metrics-including-revenue-margin-and-adjusted-ebitda-posts-record-200m-quarterly-revenue-and-over-2-2b-backlog-guides-a/
33. Press Releases - Iridium Satellite Communications, https://investor.iridium.com/press-releases
34. 1 Reason Rocket Lab Stock Could Be a Monster Winner - 24/7 Wall St., https://247wallst.com/investing/2026/09/02/1-reason-rocket-lab-stock-could-be-a-monster-winner/
35. Why Cathie Wood Is Trimming the World's Biggest Tech Stock to Bet, https://247wallst.com/investing/2026/09/24/why-cathie-wood-is-trimming-the-worlds-biggest-tech-stock-to-bet-on-a-space-company/
36. RKLB - Rocket Lab USA, Inc. Stock Price - Perplexity, https://www.perplexity.ai/finance/RKLB/earnings
37. RKLB Stock Forecast and Modeling - Reddit, https://www.reddit.com/r/RKLB/comments/1uzz59x/rklb_stock_forecast_and_modeling/
38. SpaceX Leads Smart Score While Rocket Lab's Neutron and Iridium, https://finance.biggo.com/news/d172854a-7763-43fd-a73b-362abe3a5773
39. Rocket Lab USA, Inc. Stock Price - Perplexity, https://www.perplexity.ai/finance/RKLB?comparing=RKLB,SATL,SPIR,LHX,GOMX.ST,RDW
40. Breakfast News: Rocket Lab Earnings Fail to Launch | The Motley Fool, https://www.fool.com/investing/breakfast-news/2026/08/11/breakfast-news-rocket-lab-earnings-fail-to-launch/
41. RKLB Earnings: Latest Report, Earnings Call & Financials, https://public.com/stocks/rklb/earnings
42. ROCKET LAB USA (RKLB) - Earnings Date & History, https://unusualwhales.com/stock/RKLB/earnings
43. Rocket Lab (NasdaqGS:RKLB) Stock Forecast & Analyst Predictions, https://simplywall.st/stocks/us/capital-goods/nasdaq-rklb/rocket-lab/future
44. Intuitive Machines, Inc. Stock Price - Perplexity, https://www.perplexity.ai/finance/LUNR?comparing=LUNR,EVEX,ASTS,BKSY,RDW,FLY
45. RKLB Rocket Lab Corp Stock Forecast, Predictions & Price Target, https://www.wallstreetzen.com/stocks/us/nasdaq/rklb/stock-forecast
46. Rocket Lab USA, Inc. (Form: 8-K, Received - EDGAR Online, https://content.edgar-online.com/ExternalLink/EDGAR/0000950170-24-011944.html?hash=2d4759fa7cb03b564bb5f237073308af0af199b7984388ab4df17f7428d468ba&dest=rklb-ex4_1_htm
47. All Blackrock Companies by Weight - Slickcharts, https://www.slickcharts.com/blackrock
48. AST SpaceMobile, Inc. Second Quarter 2026 Results ... - Reddit, https://www.reddit.com/r/ASTSpaceMobile/comments/1vk0dsr/ast_spacemobile_inc_second_quarter_2026_results/
49. AST SpaceMobile Q2 Earnings Call: 45 BlueBird Satellites to Build, https://news.futunn.com/en/post/77474381/ast-spacemobile-q2-earnings-call-45-bluebird-satellites-to-build
50. $LUNR Stock Hub: New Customer Orders Two IM 300 Platforms, https://www.merlintrader.com/intuitive-machines-stock-hub/
51. rklb-20250630 - SEC.gov, https://www.sec.gov/Archives/edgar/data/1819994/000162828025038936/rklb-20250630.htm
52. rocket lab corporation - SEC.gov, https://www.sec.gov/Archives/edgar/data/1819994/000175392626001085/g085783_8k.htm
53. Watch Archimedes burn! Rocket Lab fires up engine for its ... - Space, https://www.space.com/space-exploration/watch-archimedes-burn-rocket-lab-fires-up-engine-for-its-powerful-next-gen-neutron-launcher-video
54. Rocket Lab's Neutron Timeline Meets Earnings Reality Tomorrow, https://www.barchart.com/story/news/1755311/rocket-lab-s-neutron-timeline-meets-earnings-reality-tomorrowunless-the-backlog-buys-more-time
55. Rocket Lab Announces Third Quarter 2024 Financial Results, Posts, https://www.reddit.com/r/stocks/comments/1gpvw9b/rocket_lab_announces_third_quarter_2024_financial/
56. Rocket Lab announces Q3 2024 financial results — plus - SatNews, https://satnews.com/2024/11/13/rocket-lab-announces-q3-2024-financial-results-plus-mla-constellation-contract-signed/
57. RKLB (Rocket Lab) Market Cap - GuruFocus, https://www.gurufocus.com/term/mktcap/RKLB